Is Nebius Group Stock Going To $0?

Nebius Group (NBIS) has delivered explosive top-line growth—revenue surged more than 300% in the latest quarter and the shares have risen over 160% in the past year—driven by demand for AI compute and managed services and billion-dollar capacity deals with Microsoft and Meta. Management must undertake heavy near-term investment and debt to meet demand, leaving profitability and long-term fundamentals uncertain, while competition from CoreWeave and hyperscale cloud providers could constrain future growth; investors should weigh rapid revenue expansion against execution and capital-risk concerns.

Analysis

Market structure: Nebius (NBIS) and peer AI-capacity specialists (e.g., CRWV) are near-term beneficiaries as enterprise AI workloads create acute GPU/instance scarcity — NBIS’s +300% quarterly revenue surge and ~160% YTD share move imply tight supply and inelastic short-term pricing. Nvidia (NVDA) is an upstream winner (GPU pricing/power draw), while hyperscalers (MSFT, AMZN) are both customers and eventual competitors; if hyperscalers complete internal capacity builds within 12–24 months, pricing power for third-party providers will compress materially. Cross-asset: expect elevated NBIS credit spreads and option IV, stronger NVDA equity bids, and modest upward pressure on power/commodities tied to datacenter buildouts over 6–24 months.

Risk assessment: Key tail risks are (1) hyperscaler vertical integration causing >50% YoY revenue deceleration for NBIS within 12–24 months, (2) GPU supply shocks or NVDA production issues delaying NBIS capacity rollouts, and (3) NBIS debt/covenant stress if capex-funded growth outpaces cash flow. Immediate (days) risk is high IV/flow-driven pullbacks; short-term (2–6 quarters) hinge on guidance; long-term (12–36 months) depends on customer concentration (MSFT/META contracts) and margin sustainability. Monitor upcoming quarterly guidance, NVDA supply cadence, and NBIS debt raises as critical catalysts.

Trade implications: Tactical plays: 1) small, hedged exposure to NBIS to capture continuing demand but protect downside; 2) long NVDA (3–5% tactical) to ride GPU tightness; 3) pair trades long MSFT/AMZN vs short NBIS to express vertical-integration risk. Use options to define risk: buy 3–6 month calls on NVDA; buy 3-month 10% OTM puts on NBIS or sell short if NBIS misses guidance. Entry/exit: act pre-earnings with size caps and clear stop-loss triggers (see decisions).

Contrarian angles: The consensus underestimates stickiness of managed services for mid-market and latency-sensitive customers — NBIS could retain a profitable niche even if hyperscalers expand. Conversely, current NBIS valuation reflects ‘growth premium’; implied volatility suggests selling premium (covered calls/short dated strangles) may be attractive. Historical parallels (Akamai vs cloud consolidation) show specialists can survive but at lower multiples; mispricing exists if market assumes either 100% durability or 0% survivability.

Key Decisions for Investors

• Establish a tactical 2% long position in NBIS ahead of the next quarter (within 30–45 days) financed from cash — immediately buy a 3-month 10% OTM put for downside protection; if NBIS next-quarter revenue growth falls below 100% YoY or guidance is cut, liquidate the long and/or convert to a 1% net short.
• Initiate a 3–4% position in NVDA via equity or buy 3–6 month 5–10% OTM calls to capture continued GPU tightness; trim half at +50% realized gain or if NVDA announces material supply ramp that extends capacity beyond 12 months.
• Implement a pair trade: long MSFT (2–3% portfolio) and short NBIS (1–2% dollar-neutral) to express hyperscaler vertical-integration upside versus specialist risk; increase NBIS short to 3% if MSFT/AMZN announce >$5B combined AI-capex builds within 12 months.
• Sell 30–60 day covered calls on existing NBIS exposure to harvest elevated IV; alternatively, buy 9–12 month OTM puts on NBIS (tail hedge) if NBIS issues >$250M new debt or capex guidance exceeds 50% of projected operating cash flow in next 12 months.